Conmed (CNMD) Total Non-Current Liabilities (2016 - 2026)
Conmed filings provide 17 years of Total Non-Current Liabilities readings, the most recent being $1.2 billion for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 0.83% to $1.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.2 billion, a 0.83% decrease, with the full-year FY2025 number at $1.2 billion, down 2.26% from a year prior.
- Total Non-Current Liabilities hit $1.2 billion in Q1 2026 for Conmed, roughly flat from $1.2 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q2 2023 to a low of $954.4 million in Q1 2022.
- Median Total Non-Current Liabilities over the past 5 years was $1.3 billion (2022), compared with a mean of $1.3 billion.
- Biggest five-year swings in Total Non-Current Liabilities: surged 44.76% in 2023 and later fell 7.5% in 2025.
- Conmed's Total Non-Current Liabilities stood at $1.3 billion in 2022, then dropped by 0.27% to $1.3 billion in 2023, then fell by 6.51% to $1.3 billion in 2024, then decreased by 2.26% to $1.2 billion in 2025, then increased by 0.44% to $1.2 billion in 2026.
- The last three reported values for Total Non-Current Liabilities were $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025) per Business Quant data.